miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1 (vol 9, 38, 2021)

被引：2
|
作者：
不详
机构：
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2022年
关键词：
D O I：
10.21037/atm-2022-34
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] KCNQ1OT1 contributes to sorafenib resistance and programmed death-ligand-1-mediated immune escape via sponging miR-506 in hepatocellular carcinoma cells
    Zhang, Junli
    Zhao, Xiaohui
    Ma, Xiaojuan
    Yuan, Zengyan
    Hu, Miao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (05) : 1794 - 1804
  • [32] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Weidong Li
    Xuesong Dong
    Changjun He
    Gang Tan
    Ziyi Li
    Bo Zhai
    Jing Feng
    Xian Jiang
    Chang Liu
    Hongchi Jiang
    Xueying Sun
    Journal of Experimental & Clinical Cancer Research, 38
  • [33] LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Li, Weidong
    Dong, Xuesong
    He, Changjun
    Tan, Gang
    Li, Ziyi
    Zhai, Bo
    Feng, Jing
    Jiang, Xian
    Liu, Chang
    Jiang, Hongchi
    Sun, Xueying
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [34] miR-486-3p mediates sorafenib resistance through targeting FGFR4 and EGFR in hepatocellular carcinoma
    Ji, Lin
    Lin, Zhongjie
    Wan, Zhe
    Xia, Shunjie
    Jiang, Shi
    Cen, Dong
    Cai, Liuxin
    Xu, Junjie
    Cai, Xiujun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S901 - S901
  • [35] The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
    Zhang, Zhongqiang
    Tan, Xiao
    Luo, Jing
    Yao, Hongliang
    Si, Zhongzhou
    Tong, Jing-Shan
    CELL DEATH & DISEASE, 2020, 11 (10)
  • [36] miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
    Chen, Xianqing
    Tan, Wenliang
    Li, Wenxin
    Li, Wenda
    Zhu, Sicong
    Zhong, Jinyi
    Shang, Changzhen
    Chen, Yajin
    JOURNAL OF CANCER, 2019, 10 (12): : 2745 - 2753
  • [37] RETRACTED: miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma (Retracted article. See vol. 59, 2021)
    Liu, Kai
    Liu, Songyang
    Zhang, Wei
    Ji, Bai
    Wang, Yingchao
    Liu, Yahui
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1537 - 1546
  • [38] circ_LRIG3 contributes to the progression of hepatocellular carcinoma by elevating RNF38 via sponging miR-449a
    Hu, Xiaonan
    Zhou, Kaikai
    Cao, Sujuan
    Zhu, Huan
    Xie, Kaihong
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2021, 40 (02) : 103 - 114
  • [39] MiR-767-3p promotes the progression of hepatocellular carcinoma via targeting CASP-3/-9
    Wu, Maolin
    Deng, Jing
    Yao, Dejiao
    Li, Shijie
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (04): : 2926 - 2938
  • [40] Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
    Weidong Li
    Xuesong Dong
    Changjun He
    Gang Tan
    Ziyi Li
    Bo Zhai
    Jing Feng
    Xian Jiang
    Chang Liu
    Hongchi Jiang
    Xueying Sun
    Journal of Experimental & Clinical Cancer Research, 40
12345